Can I Take Vitamin D with Tadalafil (Generic)?

The direct answer

Vitamin D (as cholecalciferol or ergocalciferol) has no established pharmacokinetic interaction with tadalafil, because tadalafil is cleared through hepatic CYP3A4 while vitamin D is activated through a separate hydroxylation pathway (CYP2R1, CYP27A1, and renal CYP27B1) that does not affect CYP3A4 at supplement doses. Neither the FDA-approved tadalafil label nor the Endocrine Society's clinical practice guideline on vitamin D lists this combination as a concern. No trial has specifically tested tadalafil given together with vitamin D, so the "no interaction" conclusion is a pharmacology-based inference rather than a direct clinical finding, and it does not replace a medication review for men with cardiovascular disease, kidney disease, or a complex drug list.

That is the core, quotable answer. Everything below explains the reasoning, what is and is not backed by trial data, and what a clinician or pharmacist should still check for an individual patient.

Why this question comes up

Men prescribed tadalafil for erectile dysfunction or benign prostatic hyperplasia are frequently in an age range where vitamin D insufficiency is common, particularly with obesity, limited sun exposure, or northern latitude residence. When a patient adds a supplement to an existing prescription, it is reasonable to ask whether the two interact. Vitamin D deficiency prevalence in the general US adult population has been documented in cohort research; exact figures vary by study population, season, and the cutoff used for "deficient" versus "insufficient," so specific percentages should be checked against a current source rather than treated as fixed (Forrest & Stuhldreher, Nutr Res 2011; NIH Office of Dietary Supplements).

How tadalafil works and what actually interacts with it

Tadalafil selectively inhibits phosphodiesterase type 5 (PDE5), the enzyme that breaks down cyclic GMP in smooth muscle. Blocking PDE5 prolongs nitric-oxide-driven cGMP signaling, relaxing corpus cavernosum smooth muscle (erectile dysfunction indication), bladder-neck and prostatic smooth muscle (BPH indication), and pulmonary vascular smooth muscle (Adcirca, the 40 mg/day PAH formulation).

Tadalafil is metabolized almost entirely by hepatic CYP3A4. According to the FDA-approved prescribing information, strong CYP3A4 inhibitors (for example, ketoconazole or ritonavir) meaningfully raise tadalafil exposure, and strong CYP3A4 inducers (for example, rifampin) meaningfully lower it; the label is the authoritative source for the exact magnitude of these changes and should be checked directly for prescribing decisions rather than relied on from a summary. Nitrates are an absolute contraindication because of synergistic, severe hypotension. Alpha-blockers used for BPH also require caution because of additive blood-pressure lowering. Vitamin D does not fall into any of these categories.

How vitamin D works and where its effects overlap with tadalafil's

Vitamin D is a secosteroid prohormone. Skin synthesis or dietary intake supplies cholecalciferol (D3) or ergocalciferol (D2), which the liver converts to 25-hydroxyvitamin D (calcidiol, the storage form measured on lab tests) via CYP2R1 and CYP27A1. The kidney then converts calcidiol to the active hormone, 1,25-dihydroxyvitamin D (calcitriol), via CYP27B1. Calcitriol binds the vitamin D receptor, which is expressed in endothelial cells, vascular smooth muscle, and cardiomyocytes, and it has been linked in observational and some interventional research to blood pressure regulation and endothelial function.

None of these steps involve CYP3A4 or P-glycoprotein, the pathways relevant to tadalafil clearance. This is the mechanistic basis for saying the two do not interact pharmacokinetically. It is an inference from separate metabolic pathways, not a finding from a trial that measured tadalafil levels with and without vitamin D on board.

The pharmacodynamic question: could combined blood pressure effects matter?

Tadalafil produces a small reduction in systolic blood pressure, and vitamin D supplementation has been studied for possible modest blood pressure effects, with the more consistent signal appearing in people who start out hypertensive rather than in normotensive adults (some meta-analyses of vitamin D trials have reported small blood pressure reductions, particularly in hypertensive populations). If both effects occurred in the same person, the combined blood pressure change would likely be small in absolute terms for someone without existing hypertension. This has not been directly tested as a combination, and men who are on multiple blood-pressure medications, have low baseline blood pressure, or have a history of syncope should mention any new supplement, including vitamin D, to their prescriber before starting it alongside tadalafil.

Vitamin D deficiency and erectile function: a related but separate question

Some observational research has found lower serum 25-hydroxyvitamin D levels in men with erectile dysfunction compared with men without it, though the specific source for this association needs direct verification. This is an association, not proof that low vitamin D causes erectile dysfunction or that supplementation improves it; observational designs cannot rule out confounding by obesity, diabetes, or cardiovascular disease, all of which independently lower vitamin D levels and cause erectile dysfunction.

At least one small randomized trial reported improvement in erectile function scores after vitamin D repletion in deficient men. The exact citation details in earlier drafts of this article did not match between the in-text description and the reference list, and this claim needs direct verification against the original paper before any specific numeric result (for example, a specific point change on a symptom scale) is published as fact. Until that verification happens, the safest accurate statement is: small trial-level evidence suggests vitamin D repletion may modestly improve erectile function scores in men who are both deficient and symptomatic, but this evidence is limited, has not been replicated at scale, and did not test vitamin D in combination with tadalafil.

No trial has evaluated whether adding vitamin D to tadalafil produces better erectile function outcomes than tadalafil alone. Treating the two as an evidence-based combination therapy would overstate what is known.

Evidence-boundary statement

Established: Tadalafil is cleared via hepatic CYP3A4. Vitamin D is activated via CYP2R1, CYP27A1, and renal CYP27B1. These are distinct pathways, and neither the FDA tadalafil label nor the Endocrine Society vitamin D guideline lists an interaction between the two agents (FDA prescribing information; Holick et al., Endocrine Society guideline).

Plausible but unproven: Combined mild blood-pressure-lowering effects from tadalafil and vitamin D could theoretically add together in some individuals, particularly those who are hypertensive or on other blood pressure medications. Vitamin D repletion may have an independent, modest benefit on erectile function in men who are vitamin D deficient, based on limited trial data that has not been replicated at scale.

Not established: No dedicated pharmacokinetic or pharmacodynamic trial has co-administered tadalafil and vitamin D. Whether vitamin D improves outcomes specifically in men already taking tadalafil is untested. Any precise numeric claim about the degree of erectile function improvement from vitamin D repletion should be treated as unverified pending confirmation of the original source.

Not a substitute for individualized advice: This article does not provide a dosing recommendation for any individual patient. A treating clinician or pharmacist should confirm vitamin D dosing, monitoring, and interaction status against a patient's full medication list, kidney function, and calcium status.

Evidence-status interaction assessment: vitamin D and tadalafil

Practical points on combining the two

Vitamin D is fat-soluble, and taking it with a meal containing some fat is commonly recommended to support absorption, though the size of this effect has been debated in the literature and should not be treated as a strict requirement (Dawson-Hughes et al., J Bone Miner Res). Tadalafil absorption is not meaningfully affected by food. There is no pharmacokinetic reason to separate the timing of the two; taking both with the same meal is a reasonable, convenience-driven choice rather than a clinical requirement.

Standard vitamin D supplementation (commonly in the 600 to 4,000 IU/day range for adults, per NIH dietary reference intakes) is generally considered low risk when added to a tadalafil regimen (NIH ODS Vitamin D Fact Sheet). Higher, prescription-level repletion doses used short term for confirmed deficiency should be managed by a clinician who is tracking serum calcium and 25-hydroxyvitamin D levels, independent of tadalafil use.

Calcium is frequently co-formulated with vitamin D. Calcium does not interact with tadalafil pharmacokinetically. Hypercalcemia from over-supplementation is uncommon at typical doses but is a reason to check calcium and parathyroid hormone levels before starting high-dose vitamin D in anyone with a history of hyperparathyroidism, sarcoidosis, or other granulomatous disease, and in anyone on a thiazide diuretic, which reduces urinary calcium excretion.

Who should talk to a prescriber before combining these

Most men taking standard-dose tadalafil for erectile dysfunction or BPH do not need a dedicated medical consultation purely to add standard-dose vitamin D, though mentioning it at a routine visit is good practice. A prescriber conversation is warranted before combining the two for:

• Men taking tadalafil 40 mg/day for pulmonary arterial hypertension, who typically have more complex cardiovascular regimens
• Anyone on a strong CYP3A4 inhibitor or inducer, where the overall tadalafil dosing plan needs review regardless of vitamin D
• Anyone on multiple blood pressure medications or with a history of low blood pressure or syncope
• Anyone considering high-dose vitamin D repletion (well above standard supplement doses) who has kidney disease, hyperparathyroidism, or granulomatous disease
• Anyone on a thiazide diuretic who plans to take vitamin D doses above the standard supplement range

When to seek urgent care

Chest pain, fainting, a sudden and prolonged erection lasting more than four hours (priapism), or sudden vision or hearing loss while taking tadalafil are urgent medical situations regardless of any supplement use. Vitamin D is not a known cause or contributor to any of these events, and adding or stopping it is not an appropriate response to these symptoms.

Delivery note for editorial and medical review: The original draft included a direct quotation attributed to the Endocrine Society guideline; it has been converted to paraphrase here because the exact wording could not be verified against the source document. It also cited a 2021 Andrologia trial (PMID 33368449) in the body text while the reference list described a different paper (Canguven et al., Aging Male, 2017); this mismatch is flagged above and the specific numeric result (IIEF-5 change of 3.1 vs. 0.4) has been removed pending verification of which paper is correct. A reference to an unrelated hypogonadism prevalence study (PMID 16846397) was removed because it did not support any claim on this page. Several precise percentages (blood pressure changes, deficiency prevalence, absorption increases, magnitude of CYP3A4 interaction effects) have been softened or removed where the provided source material did not directly substantiate the specific number; a clinical reviewer should confirm any of these figures against primary sources before restoring precise numbers.